References
- Mansouri K, Guidotti J, Rao HL, et al. Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN gel implant surgery: 1-year results. J Glaucoma. 2018;27(2):140–147. doi:10.1097/IJG.0000000000000858
- Lenzhofer M, Kersten-Gomez I, Sheybani A, et al. Four-year results of a minimally invasive transscleral glaucoma get stent implantation in a prospective multi-centre study. Clin Exp Ophthalmol. 2019;47(5):581–587. doi:10.1111/ceo.13463
- Gillmann K, Bravetti GE, Mermoud A, et al. XEN gel stent in pseudoexfoliative glaucoma: 2-year results of a prospective evaluation. J Glaucoma. 2019;28(8):676–684. doi:10.1097/IJG.0000000000001295
- Reitsamer H, Sng C, Vera V, et al. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019;257:983–996. doi:10.1007/s00417-019-04251-z
- Gabbay IE, Allen F, Morley C, et al. Efficacy and safety data for the XEN45 implant at 2 years: a retrospective analysis. Br J Ophthalmol. 2020;104:1125–1130. doi:10.1136/bjophthalmol-2019-313870
- Yuan L, Lai G, Raiciulescu S, Kim W. Outcomes of ab interno placement versus ab externo transconjunctival placement of Xen 45 gel stents. Presented at the American Glaucoma Society Annual Meeting; February 27; 2020; Washington, DC.
- Gallardo M, Porter M, Vincent L, et al. Outcomes following implantation of an anterior segment drainage device (Xen45 Gel Stent) via an ab-interno or ab-externo approach in patients with uncontrolled open angle glaucoma. Presented at the American Glaucoma Society Annual Meeting. February 27; 2020; Washington, DC.
- Purgert RJ, Lin MM, Mehren N, et al. Outcomes of ab interno versus ab externo XEN gel stent implantation. Presented at the American Glaucoma Society Annual Meeting. February 27; 2020; Washington, DC.
- Gagne S, Yuen D, Cohen S Slit lamp implantation of a Gel Microstent. Presented at ASCRS Annual Meeting. May 3–7; 2019; San Diego, CA.
- Vera V, Ahmed IK, Stalmans I, Reitsamer H. Gel stent implantation – recommendations for preoperative assessment, surgical technique, and postoperative management. US Ophthalmic Rev. 2018;11(1):38–46. doi:10.17925/USOR.2018.11.1.38
- Sherwood MB, Grierson I, Milgar L, Hitchings RA. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon’s capsule in glaucomatous patients. Ophthalmology. 1989;96:327–335. doi:10.1016/S0161-6420(89)32888-0
- Baudouin C, Liang H, Hamard P, et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology. 2008;115:109–115. doi:10.1016/j.ophtha.2007.01.036
- Breusegem C, Spielberg L, Van Ginderdeuren R, et al. Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. Ophthalmology. 2010;117(7):1324–1330. doi:10.1016/j.ophtha.2009.11.038
- Ong JA, Wu P, Ahmed IIK. Outcomes of ab interno gelatin microstent with MMC using targeted supra-Tenon’s placement. Presented at the American Glaucoma Society Annual Meeting. February 27; 2020; Washington, DC.
- Lenzhofer M, Strohmaier C, Sperl P, et al. Effect of the outer stent position on efficacy after minimally invasive transscleral glaucoma gel stent implantation. Acta Ophthalmol. 2019;97(8):e1105–1111. doi:10.1111/aos.14167
- Vera V, Sheybani A, Lindfield D, Stalmans I, Ahmed IIK. Recommendations for the management of elevated intraocular pressure due to bleb fibrosis after XEN gel stent implantation. Clin Ophthalmol. 2019;13:685–694. doi:10.2147/OPTH.S195457
- Figueroa-Vercellino JP, Peraza-Nieves JE, Milla E, Pazos M. Relationship between the location of the XEN stent glaucoma implant (with respect to the Tenon capsule) and the intraocular pressure. J Fr Ophtalmol. 2019;42(4):421–422. doi:10.1016/j.jfo.2018.10.009